214 related articles for article (PubMed ID: 35213357)
1. Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.
Liu S; Li R; Liu Q; Sun D; Yang H; Pan H; Wang L; Song S
Cancer Biomark; 2022; 33(2):249-259. PubMed ID: 35213357
[TBL] [Abstract][Full Text] [Related]
2. Value of [
Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
[TBL] [Abstract][Full Text] [Related]
3. The feasibility of
Liu S; Xia L; Yang Z; Ge H; Wang C; Pan H; Song S; Zhou Z
Cancer Imaging; 2020 Sep; 20(1):63. PubMed ID: 32912310
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of lymph node-to-primary tumor standardized uptake value ratio in invasive squamous cell carcinoma of uterine cervix.
Chung HH; Cheon GJ; Kim JW; Park NH; Song YS
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1862-1869. PubMed ID: 28534183
[TBL] [Abstract][Full Text] [Related]
5. Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
Li X; Xu C; Yu Y; Guo Y; Sun H
BMC Cancer; 2021 Jul; 21(1):866. PubMed ID: 34320931
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
[TBL] [Abstract][Full Text] [Related]
8. PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features.
Esfahani SA; Torrado-Carvajal A; Amorim BJ; Groshar D; Domachevsky L; Bernstine H; Stein D; Gervais D; Catalano OA
Mol Imaging Biol; 2022 Feb; 24(1):60-69. PubMed ID: 34622425
[TBL] [Abstract][Full Text] [Related]
9. [
Ferreira M; Lovinfosse P; Hermesse J; Decuypere M; Rousseau C; Lucia F; Schick U; Reinhold C; Robin P; Hatt M; Visvikis D; Bernard C; Leijenaar RTH; Kridelka F; Lambin P; Meyer PE; Hustinx R
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3432-3443. PubMed ID: 33772334
[TBL] [Abstract][Full Text] [Related]
10. Prediction of outcome using pretreatment
Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
Chung HH; Kim JW; Han KH; Eo JS; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Gynecol Oncol; 2011 Feb; 120(2):270-4. PubMed ID: 21109300
[TBL] [Abstract][Full Text] [Related]
12. (
Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
Yilmaz B; Dağ S; Ergul N; Çermik TF
Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896
[TBL] [Abstract][Full Text] [Related]
14. Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics.
Yusufaly TI; Zou J; Nelson TJ; Williamson CW; Simon A; Singhal M; Liu H; Wong H; Saenz CC; Mayadev J; McHale MT; Yashar CM; Eskander R; Sharabi A; Hoh CK; Obrzut S; Mell LK
J Nucl Med; 2022 Jul; 63(7):1087-1093. PubMed ID: 34711618
[TBL] [Abstract][Full Text] [Related]
15. False negative rate at
Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
[TBL] [Abstract][Full Text] [Related]
16. Radiomic analysis for predicting prognosis of colorectal cancer from preoperative
Lv L; Xin B; Hao Y; Yang Z; Xu J; Wang L; Wang X; Song S; Guo X
J Transl Med; 2022 Feb; 20(1):66. PubMed ID: 35109864
[TBL] [Abstract][Full Text] [Related]
17. Application of 18F-FDG PET/CT imaging radiomics in the differential diagnosis of single-nodule pulmonary metastases and second primary lung cancer in patients with colorectal cancer.
Yu Y; Zhu J; Sang S; Yang Y; Zhang B; Deng S
J Cancer Res Ther; 2024 Apr; 20(2):599-607. PubMed ID: 38687930
[TBL] [Abstract][Full Text] [Related]
18. The predictive recurrence value of MTV-s as an 18F-FDG PET/CT index in patients with IIB-IVA cervical cancer.
Deng C; Ding D; Wang M
Postgrad Med; 2021 May; 133(4):436-443. PubMed ID: 33620285
[No Abstract] [Full Text] [Related]
19.
Tsujikawa T; Rahman T; Yamamoto M; Yamada S; Tsuyoshi H; Kiyono Y; Kimura H; Yoshida Y; Okazawa H
Ann Nucl Med; 2017 Nov; 31(9):678-685. PubMed ID: 28815452
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ¹⁸F-FDG PET/CT in early-stage cervical carcinoma.
Yu L; Jia C; Wang X; Lu P; Tian M; Wang W; Lou G
Am J Med Sci; 2011 Feb; 341(2):96-100. PubMed ID: 21030858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]